Birth Control May Lower MS Odds

NOVEMBER 01, 2005

Women taking oral contraceptives for 3 years saw a reduction in the odds of developing multiple sclerosis (MS). The study, as reported in the Archives of Neurology (September 2005), compared 106 women newly diagnosed with MS between January 1, 1993, and December 31, 2000, with 1001 women without the disease. The participants were chosen for the study based on a research database that included medical and pharmacy records for 3 million British patients.

"The incidence of MS in [oral contraceptive] users was 40% lower than in nonusers," the investigators reported. "Women had a higher risk of developing first symptoms of MS in the 6 months following a pregnancy and a nonsignificant lower risk during pregnancy, compared with those with no pregnancy.... This is consistent with studies on the effect of pregnancy in patients with MS and the immunological changes associated with pregnancy."




SHARE THIS SHARE THIS
0

Treatment of Melanoma 

In this Pharmacy Times program for Health Systems Pharmacists, Nanaz Amini, PharmD, RPh, MS, of the Angles Clinic, provides a pharmacist’s perspective on the management of melanoma.  


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.